JPRN-jRCT2080221322未知2 期
Phase IIa study of T-5224 in RA patients
Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)0 个研究点开始时间: 2010年12月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Male or female.
- •-Subject who have a diagnosis of Rheumatoid Arthritis by the ACR criteria.
- •-Age greater or 20 years and less than 65 years old.
- •-Subject who diagnosed to class 1-3 of Steinblocker dysfunction classification.
排除标准
- •-Subject with autoimmune disease except RA and SS.
- •-Subject who is pregnancy, has possibility of pregnancy, hopes for pregnancy, is suckling.
研究者
相似试验
已完成
2 期
A Phase II/III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response to Methotrexate (MTX) TherapyRheumatoid Arthritis (RA)JPRN-jRCT2080223971Taisho Pharmaceutical co., LTD381
已完成
2 期
A Phase 2 study of SAR245409 in patients with relapsed or refractory mantle cell lymphoma, follicular lymphoma, or chronic lymphocytic leukemia/small lymphocytic lymphomachronic lymphocytic leukemia (CLL)non Hodgkin lymphoma (NHL)1002432410025320NL-OMON36096Sanofi-aventis10
进行中（未招募）
不适用
A study of investigational SAR245409 in patients with certain lymphoma or leukemiaymphomaMedDRA version: 13.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001616-57-BEsanofi-aventis recherche & développement138
进行中（未招募）
不适用
A study of investigational SAR245409 in patients with certain lymphoma or leukemiaEUCTR2011-001616-57-DEsanofi-aventis recherche & développement180
未知
2 期
Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Pilot studyAcute myocardial infarctionJPRN-jRCT2080221349TOA EIYO LTD.